Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in Br J Haematol Retrieve available abstracts of 236 articles: HTML format

Single Articles

May 2009
1. MARIN D , Khorashad JS, Foroni L, Milojkovic D, et al
   Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?
   Br J Haematol. 2009;145:373-5.
   PubMed     Related articles    Abstract available
   
   
   
2. BURNETT AK , Milligan D, Goldstone A, Prentice A, et al
   The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.
   Br J Haematol. 2009;145:318-32.
   PubMed     Related articles    Abstract available
   
   
   
3. SOUWER Y , Chamuleau ME, van de Loosdrecht AA, Tolosa E, et al
   Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
   Br J Haematol. 2009;145:334-43.
   PubMed     Related articles    Abstract available
   
   
   
4. SAULLE E , Riccioni R, Coppola S, Parolini I, et al
   Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
   Br J Haematol. 2009;145:399-411.
   PubMed     Related articles    Abstract available
   
   
   
5. 
   Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.
   Br J Haematol. 2009;145:376-88.
   PubMed     Related articles    Abstract available
   
   
   
6. BUNCE C
   Where now in elderly AML?
   Br J Haematol. 2009;145:333.
   PubMed     Related articles   
   
   
   
7. HUBACEK P , Virgili A, Ward KN, Pohlreich D, et al
   HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis.
   Br J Haematol. 2009;145:394-8.
   PubMed     Related articles    Abstract available
   
   
   
8. DI IASIO MG , Secchiero P, Tiribelli M, Zauli G, et al
   Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients.
   Br J Haematol. 2009;145:424-6.
   PubMed     Related articles   
   
   
   
9. GALLIPOLI P , Tang A, Leach M
   Cortical blindness due to sagittal sinus thrombosis in acute lymphoblastic leukaemia.
   Br J Haematol. 2009;145:270.
   PubMed     Related articles   
   
   
   April 2009
10. STEVENS JM , Macdougall F, Jenner M, Oakervee H, et al
    Patterns of recruitment into acute myeloid leukaemia (AML) 15 and outcome for young patients with AML at a single referral centre.
    Br J Haematol. 2009;145:40-4.
    PubMed     Related articles    Abstract available
    
    
    
11. TAYLOR GM , Richards S, Wade R, Hussain A, et al
    Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?
    Br J Haematol. 2009;145:87-95.
    PubMed     Related articles    Abstract available
    
    
    
12. RIZ I , Hawley TS, Johnston H, Hawley RG, et al
    Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
    Br J Haematol. 2009;145:140-3.
    PubMed     Related articles   
    
    
    
13. WONG KF , Chow E, Siu LL, Wong WS, et al
    Acute promyelocytic leukaemia with cryptic PML-RARA fusion.
    Br J Haematol. 2009;145:2.
    PubMed     Related articles   
    
    
    March 2009
14. JAIME-PEREZ JC , Rodriguez-Romo LN, Gonzalez-Llano O, Chapa-Rodriguez A, et al
    Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
    Br J Haematol. 2009;144:794-5.
    PubMed     Related articles   
    
    
    
15. MASAMOTO Y , Nannya Y, Arai S, Koike Y, et al
    Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
    Br J Haematol. 2009;144:798-9.
    PubMed     Related articles   
    
    
    
16. MEKLAT F , Zhang Y, Shahriar M, Ahmed SU, et al
    Identification of protamine 1 as a novel cancer-testis antigen in early chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:660-6.
    PubMed     Related articles    Abstract available
    
    
    
17. DESMOND R , McDerra J, Kelly K, Smith O, et al
    Multiple vertebral collapse as a presentation of childhood acute lymphoblastic leukaemia.
    Br J Haematol. 2009;144:627.
    PubMed     Related articles   
    
    
    
18. GRIBBEN JG , Hallek M
    Rediscovering alemtuzumab: current and emerging therapeutic roles.
    Br J Haematol. 2009;144:818-31.
    PubMed     Related articles    Abstract available
    
    
    
19. LAPALOMBELLA R , Gowda A, Joshi T, Mehter N, et al
    The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:848-55.
    PubMed     Related articles    Abstract available
    
    
    
20. HEIDEL F , Lipka DB, Mirea FK, Mahboobi S, et al
    Bis(1H-indol-2-yl)methanones are effective inhibitors of FLT3-ITD tyrosine kinase and partially overcome resistance to PKC412A in vitro.
    Br J Haematol. 2009;144:865-74.
    PubMed     Related articles    Abstract available
    
    
    
21. JO A , Tsukimoto I, Ishii E, Asou N, et al
    Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis.
    Br J Haematol. 2009;144:917-29.
    PubMed     Related articles    Abstract available
    
    
    
22. GIEBEL S , Krawczyk-Kulis M, Kyrcz-Krzemien S, Haus O, et al
    Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia?
    Br J Haematol. 2009;144:970-2.
    PubMed     Related articles   
    
    
    
23. GAIKWAD A , Rye CL, Devidas M, Heerema NA, et al
    Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.
    Br J Haematol. 2009;144:930-2.
    PubMed     Related articles    Abstract available
    
    
    
24. PAULSSON K , An Q, Moorman AV, Parker H, et al
    Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia.
    Br J Haematol. 2009;144:838-47.
    PubMed     Related articles    Abstract available
    
    
    February 2009
25. KANG MH , Harutyunyan N, Hall CP, Papa RA, et al
    Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma.
    Br J Haematol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
26. RICCI C , Onida F, Servida F, Radaelli F, et al
    In vitro anti-leukaemia activity of sphingosine kinase inhibitor.
    Br J Haematol. 2009;144:350-7.
    PubMed     Related articles    Abstract available
    
    
    
27. KHANIM FL , Bradbury CA, Arrazi J, Hayden RE, et al
    Elevated FOSB-expression; a potential marker of valproate sensitivity in AML.
    Br J Haematol. 2009;144:332-41.
    PubMed     Related articles    Abstract available
    
    
    
28. RICCIONI R , Diverio D, Riti V, Buffolino S, et al
    Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.
    Br J Haematol. 2009;144:376-87.
    PubMed     Related articles    Abstract available
    
    
    
29. ZEIDLER C , Germeshausen M, Klein C, Welte K, et al
    Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.
    Br J Haematol. 2009;144:459-67.
    PubMed     Related articles    Abstract available
    
    
    
30. BROOKE G , Rossetti T, Pelekanos R, Ilic N, et al
    Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials.
    Br J Haematol. 2009;144:571-9.
    PubMed     Related articles    Abstract available
    
    
    
31. REISMULLER B , Attarbaschi A, Peters C, Dworzak MN, et al
    Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group.
    Br J Haematol. 2009;144:559-70.
    PubMed     Related articles    Abstract available
    
    
    
32. PAPADAKI C , Dufour A, Seibl M, Schneider S, et al
    Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor.
    Br J Haematol. 2009;144:517-23.
    PubMed     Related articles    Abstract available
    
    
    
33. ROWE JM
    Optimal management of adults with ALL.
    Br J Haematol. 2009;144:468-83.
    PubMed     Related articles    Abstract available
    
    
    
34. CHEUNG AM , Chow HC, Liang R, Leung AY, et al
    A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia.
    Br J Haematol. 2009;144:484-91.
    PubMed     Related articles    Abstract available
    
    
    
35. KARRMAN K , Kjeldsen E, Lassen C, Isaksson M, et al
    The t(X;7)(q22;q34) in paediatric T-cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T-cell receptor beta locus.
    Br J Haematol. 2009;144:546-51.
    PubMed     Related articles    Abstract available
    
    
    
36. BOMBEN R , Dal Bo M, Capello D, Forconi F, et al
    Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Br J Haematol. 2009;144:492-506.
    PubMed     Related articles    Abstract available
    
    
    
37. MUZIO M , Scielzo C, Bertilaccio MT, Frenquelli M, et al
    Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
    Br J Haematol. 2009;144:507-16.
    PubMed     Related articles    Abstract available
    
    
    
38. NOURSE J , Jones K, Gandhi MK
    The role of Epstein-Barr virus in Richter syndrome.
    Br J Haematol. 2009;144:613.
    PubMed     Related articles   
    
    
    January 2009
39. BOHMER FD , Uecker A
    A substrate peptide for the FLT3 receptor tyrosine kinase.
    Br J Haematol. 2009;144:127-30.
    PubMed     Related articles    Abstract available
    
    
    
40. MOTWANI J , Jesson J, Sturch E, Jones S, et al
    Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy: results from a single UK centre.
    Br J Haematol. 2009;144:133-5.
    PubMed     Related articles   
    
    
    
41. SCHARN N , Ballmaier M, Reinhardt K, Ehlers S, et al
    CSF3R mutations in paediatric acute myeloid leukaemia.
    Br J Haematol. 2009;144:140-2.
    PubMed     Related articles   
    
    
    
42. SCHWEIGHOFER CD , Ritgen M, Eichhorst BF, Busch R, et al
    Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).
    Br J Haematol. 2009;144:95-8.
    PubMed     Related articles    Abstract available
    
    
    
43. KARLSSON C , Lundin J, Kimby E, Kennedy B, et al
    Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:78-85.
    PubMed     Related articles    Abstract available
    
    
    
44. HATFIELD K , Oyan AM, Ersvaer E, Kalland KH, et al
    Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators.
    Br J Haematol. 2009;144:53-68.
    PubMed     Related articles    Abstract available
    
    
    
45. RYAN J , Quinn F, Meunier A, Boublikova L, et al
    Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
    Br J Haematol. 2009;144:107-15.
    PubMed     Related articles    Abstract available
    
    
    
46. BOUZAR AB , Boxus M, Defoiche J, Berchem G, et al
    Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Br J Haematol. 2009;144:41-52.
    PubMed     Related articles    Abstract available
    
    
    
47. GREEN L , Coumbe A, Sawicka E, De Lord C, et al
    Mycobacterium kansasii in a patient with hairy cell leukaemia.
    Br J Haematol. 2009;144:2.
    PubMed     Related articles   
    
    
    
48. DEAMBROGI C , Cresta S, Cerri M, Rasi S, et al
    14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:131-3.
    PubMed     Related articles   
    
    
    
49. ALBANO F , Anelli L, Zagaria A, Liso V, et al
    MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9).
    Br J Haematol. 2009;144:271-3.
    PubMed     Related articles   
    
    
    
50. NUCKEL H , Frey UH, Sellmann L, Collins CH, et al
    The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:268-70.
    PubMed     Related articles   
    
    
    
51. PRATT G , Harding S, Holder R, Fegan C, et al
    Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:217-22.
    PubMed     Related articles    Abstract available
    
    
    
52. DALMAZZO LF , Jacomo RH, Marinato AF, Figueiredo-Pontes LL, et al
    The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Br J Haematol. 2009;144:223-9.
    PubMed     Related articles    Abstract available
    
    
    
53. MOHAMEDALI A , Guinn BA, Sahu S, Thomas NS, et al
    Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients.
    Br J Haematol. 2009;144:263-5.
    PubMed     Related articles   
    
    
    
54. HARRISON CJ
    Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia.
    Br J Haematol. 2009;144:147-56.
    PubMed     Related articles    Abstract available
    
    
    December 2008
55. AMREIN L , Hernandez TA, Ferrario C, Johnston J, et al
    Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.
    Br J Haematol. 2008;143:698-706.
    PubMed     Related articles    Abstract available
    
    
    
56. NAHI H , Jansson M, Sander B, Ljungman P, et al
    Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient.
    Br J Haematol. 2008;143:751-3.
    PubMed     Related articles   
    
    
    
57. CHEVALLIER P , Robillard N, Ayari S, Guillaume T, et al
    Persistence of CD33 expression at relapse in CD33(+) acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease.
    Br J Haematol. 2008;143:744-6.
    PubMed     Related articles   
    
    
    
58. JENKINS C , Hewamana S, Gilkes A, Neelakantan S, et al
    Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.
    Br J Haematol. 2008;143:661-71.
    PubMed     Related articles    Abstract available
    
    
    
59. LI WW , Hutnik M, Gehr G
    Antiangiogenesis in haematological malignancies.
    Br J Haematol. 2008;143:622-31.
    PubMed     Related articles    Abstract available
    
    
    
60. ELSE M , Smith AG, Cocks K, Richards SM, et al
    Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial.
    Br J Haematol. 2008;143:690-7.
    PubMed     Related articles    Abstract available
    
    
    
61. LATAGLIATA R , Breccia M, Fazi P, Iacobelli S, et al
    Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia.
    Br J Haematol. 2008;143:681-9.
    PubMed     Related articles    Abstract available
    
    
    
62. SOVINZ P , Lackner H, Urban C
    Recurrent episodes of fever and pancytopenia due to haemophagocytosis during maintenance therapy for acute myeloid leukaemia.
    Br J Haematol. 2008;143:605.
    PubMed     Related articles   
    
    
    November 2008
63. BHATLA D , Gerbing RB, Alonzo TA, Conner H, et al
    Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.
    Br J Haematol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
64. AU WY , Ha SY, Chow EY, Wan TS, et al
    A unique case of familial leukaemia: maternal puerperal leukaemia followed by infantile leukaemia with monosomy 7.
    Br J Haematol. 2008;143:445-6.
    PubMed     Related articles   
    
    
    
65. ROTH A , de Beer D, Nuckel H, Sellmann L, et al
    Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.
    Br J Haematol. 2008;143:383-6.
    PubMed     Related articles    Abstract available
    
    
    
66. BROWN JR , Neuberg D, Phillips K, Reynolds H, et al
    Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
    Br J Haematol. 2008;143:361-8.
    PubMed     Related articles    Abstract available
    
    
    
67. ZHURAVLEVA J , Paggetti J, Martin L, Hammann A, et al
    MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish.
    Br J Haematol. 2008;143:378-82.
    PubMed     Related articles    Abstract available
    
    
    
68. YANADA M , Sugiura I, Takeuchi J, Akiyama H, et al
    Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
    Br J Haematol. 2008;143:503-10.
    PubMed     Related articles    Abstract available
    
    
    
69. BRETHON B , Yakouben K, Oudot C, Boutard P, et al
    Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia.
    Br J Haematol. 2008;143:541-7.
    PubMed     Related articles    Abstract available
    
    
    
70. FORCONI F , Rinaldi A, Kwee I, Sozzi E, et al
    Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
    Br J Haematol. 2008;143:532-6.
    PubMed     Related articles    Abstract available
    
    
    
71. CAMPANA D
    Status of minimal residual disease testing in childhood haematological malignancies.
    Br J Haematol. 2008;143:481-9.
    PubMed     Related articles    Abstract available
    
    
    October 2008
72. CHTIOUI H , Millius C, Lammle B, Lauterburg BH, et al
    Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation.
    Br J Haematol. 2008.
    PubMed     Related articles   
    
    
    
73. BENTHAUS T , Schneider F, Mellert G, Zellmeier E, et al
    Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia.
    Br J Haematol. 2008;143:230-9.
    PubMed     Related articles    Abstract available
    
    
    
74. DEFOICHE J , Debacq C, Asquith B, Zhang Y, et al
    Reduction of B cell turnover in chronic lymphocytic leukaemia.
    Br J Haematol. 2008;143:240-7.
    PubMed     Related articles    Abstract available
    
    
    
75. CERVETTI G , Galimberti S, Andreazzoli F, Fazzi R, et al
    Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.
    Br J Haematol. 2008;143:296-8.
    PubMed     Related articles   
    
    
    
76. MUIRHEAD CR
    Chronic lymphocytic leukaemia: an overview of aetiology--comment.
    Br J Haematol. 2008;143:295-6.
    PubMed     Related articles   
    
    
    
77. SILBERSTEIN L , Johnston C, Bhagat A, Tibi L, et al
    Pituitary apoplexy during induction chemotherapy for acute myeloid leukaemia.
    Br J Haematol. 2008;143:151.
    PubMed     Related articles   
    
    
    
78. VAN VLIERBERGHE P , Pieters R, Beverloo HB, Meijerink JP, et al
    Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
    Br J Haematol. 2008;143:153-68.
    PubMed     Related articles    Abstract available
    
    
    September 2008
79. CAZIN B , Divine M, Lepretre S, Travade P, et al
    High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia.
    Br J Haematol. 2008;143:54-9.
    PubMed     Related articles    Abstract available
    
    
    
80. BEESLEY AH , Weller RE, Kees UR
    The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse.
    Br J Haematol. 2008;142:1000-2.
    PubMed     Related articles   
    
    
    
81. SUTTON L , Chaoui D, Cazin B, Azar N, et al
    Autologous activated macrophages (MAK) coated ex vivo with humanized anti-CD20 monoclonal antibodies can eradicate minimal residual disease in chronic lymphocytic leukaemia in clinical response.
    Br J Haematol. 2008;142:996-8.
    PubMed     Related articles   
    
    
    
82. ROOS C , Stenke L, Ohm L, Widell S, et al
    Clinical imatinib mesylate treatment induces early normalisation of aberrant neutrophil leukotriene C4 synthase expression and activity in chronic myeloid leukaemia.
    Br J Haematol. 2008;142:992-5.
    PubMed     Related articles   
    
    
    
83. PACKHAM G
    The role of NF-kappaB in lymphoid malignancies.
    Br J Haematol. 2008;143:3-15.
    PubMed     Related articles    Abstract available
    
    
    
84. BARRETT AJ
    Understanding and harnessing the graft-versus-leukaemia effect.
    Br J Haematol. 2008;142:877-88.
    PubMed     Related articles    Abstract available
    
    
    
85. COLL-MULET L , Santidrian AF, Cosialls AM, Iglesias-Serret D, et al
    Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia.
    Br J Haematol. 2008;142:793-801.
    PubMed     Related articles    Abstract available
    
    
    
86. LO KC , Chalker J, Strehl S, Neat M, et al
    Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
    Br J Haematol. 2008;142:934-45.
    PubMed     Related articles    Abstract available
    
    
    
87. JOST E , Schmid J, Wilop S, Schubert C, et al
    Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Br J Haematol. 2008;142:745-53.
    PubMed     Related articles    Abstract available
    
    
    
88. CASCAVILLA N , D'Arena G, Greco MM, Melillo L, et al
    Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia.
    Br J Haematol. 2008;142:852-3.
    PubMed     Related articles   
    
    
    
89. OMOTI CE , Omoti AE
    Richter syndrome: a review of clinical, ocular, neurological and other manifestations.
    Br J Haematol. 2008;142:709-16.
    PubMed     Related articles    Abstract available
    
    
    
90. GRIER DD , Al-Quran SZ, Gray B, Li Y, et al
    Intracranial myeloid sarcoma.
    Br J Haematol. 2008;142:681.
    PubMed     Related articles   
    
    
    August 2008
91. ABROMOWITCH M , Sposto R, Perkins S, Zwick D, et al
    Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group.
    Br J Haematol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
92. ISHITSUKA K , Ikeda S, Utsunomiya A, Saburi Y, et al
    Smouldering adult T-cell leukaemia/lymphoma: a follow-up study in Kyushu.
    Br J Haematol. 2008.
    PubMed     Related articles   
    
    
    
93. CAVAZZINI F , Hernandez JA, Gozzetti A, Russo Rossi A, et al
    Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
    Br J Haematol. 2008;142:529-37.
    PubMed     Related articles    Abstract available
    
    
    
94. LANE SW , Fairbairn DJ, McCarthy C, Nandini A, et al
    Leukaemia cutis in atypical chronic myeloid leukaemia with a t(9;22) (p24;q11.2) leading to BCR-JAK2 fusion.
    Br J Haematol. 2008;142:503.
    PubMed     Related articles   
    
    
    
95. JOSE-ENERIZ ES , Roman-Gomez J, Cordeu L, Ballestar E, et al
    BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia.
    Br J Haematol. 2008;142:571-82.
    PubMed     Related articles    Abstract available
    
    
    
96. MURAMATSU H , Kato K, Watanabe N, Matsumoto K, et al
    Risk factors for early death in neonates with Down syndrome and transient leukaemia.
    Br J Haematol. 2008;142:610-5.
    PubMed     Related articles    Abstract available
    
    
    
97. GUNAWARDANA C , Austen B, Powell JE, Fegan C, et al
    South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients.
    Br J Haematol. 2008;142:606-9.
    PubMed     Related articles    Abstract available
    
    
    
98. LIN TT , Hewamana S, Ward R, Taylor H, et al
    Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient.
    Br J Haematol. 2008;142:595-605.
    PubMed     Related articles    Abstract available
    
    
    
99. CRAIG J , Walker K, Sales M, Cunningham J, et al
    Sequential tyrosine kinase inhibitor therapy: sustained disease remission in Philadelphia-positive erythroleukaemia.
    Br J Haematol. 2008;142:674-5.
    PubMed     Related articles   
    
    
    July 2008
100. GREY M
     Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
     Br J Haematol. 2008;142:1.
     PubMed     Related articles   
     
     
     
101. HUH YO , Lin KI, Vega F, Schlette E, et al
     MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis.
     Br J Haematol. 2008;142:36-44.
     PubMed     Related articles    Abstract available
     
     
     
102. DORES GM , Matsuno RK, Weisenburger DD, Rosenberg PS, et al
     Hairy cell leukaemia: a heterogeneous disease?
     Br J Haematol. 2008;142:45-51.
     PubMed     Related articles    Abstract available
     
     
     
103. OTTEN J , Schultze A, Schafhausen P, Otterstetter S, et al
     Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.
     Br J Haematol. 2008;142:115-8.
     PubMed     Related articles    Abstract available
     
     
     
104. BARBARROJA N , Siendones E, Torres LA, Luque MJ, et al
     MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
     Br J Haematol. 2008;142:27-35.
     PubMed     Related articles    Abstract available
     
     
     
105. MACLEOD RA , Drexler HG
     Leukaemia cell lines are robust in vitro models.
     Br J Haematol. 2008;142:137-8.
     PubMed     Related articles   
     
     
     
106. LUCENA-ARAUJO AR , Panepucci RA, dos Santos GA, Jacomo RH, et al
     The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity.
     Br J Haematol. 2008;142:74-8.
     PubMed     Related articles    Abstract available
     
     
     June 2008
107. CENFRA N , De Cave F, Minotti C, Ghia E, et al
     An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint.
     Br J Haematol. 2008;.
     PubMed     Related articles   
     
     
     
108. KOHLMANN A , Kipps TJ, Rassenti LZ, Downing JR, et al
     An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.
     Br J Haematol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
109. ZASSADOWSKI F , Ades L, Schlageter MH, Chevret S, et al
     Auer rods and differentiation in acute promyelocytic leukemia.
     Br J Haematol. 2008;.
     PubMed     Related articles   
     
     
     
110. BERNASCONI P
     Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
     Br J Haematol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
111. LONNERHOLM G , Frost BM, Abrahamsson J, Behrendtz M, et al
     Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia.
     Br J Haematol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
112. GUERIN E , Mahon FX, Lippert E
     Bundles of Auer rods in blast cells and mature neutrophils in a non-promyelocytic acute myeloblastic leukaemia.
     Br J Haematol. 2008;141:749.
     PubMed     Related articles   
     
     
     
113. ROBINSON BW , Behling KC, Gupta M, Zhang AY, et al
     Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.
     Br J Haematol. 2008;141:827-39.
     PubMed     Related articles    Abstract available
     
     
     
114. OVERES IM , de Rijke B, van Horssen-Zoetbrood A, Fredrix H, et al
     Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis.
     Br J Haematol. 2008;141:799-807.
     PubMed     Related articles    Abstract available
     
     
     
115. OMMEN HB , Nyvold CG, Braendstrup K, Andersen BL, et al
     Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.
     Br J Haematol. 2008;141:782-91.
     PubMed     Related articles    Abstract available
     
     
     
116. CHU M , Siegmund KD, Hao QL, Crooks GM, et al
     Inferring relative numbers of human leucocyte genome replications.
     Br J Haematol. 2008;141:862-71.
     PubMed     Related articles    Abstract available
     
     
     
117. MANCINI M , Zuffa E, Veljkovic N, Brusa G, et al
     IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia.
     Br J Haematol. 2008;141:899-902.
     PubMed     Related articles   
     
     
     
118. NGO NT , Lampert IA, Naresh KN
     Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
     Br J Haematol. 2008;141:771-81.
     PubMed     Related articles    Abstract available
     
     
     May 2008
119. FULLER SJ , Papaemmanuil E, McKinnon L, Webb E, et al
     Analysis of a large multi-generational family provides insight into the genetics of chronic lymphocytic leukemia.
     Br J Haematol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
120. YOSHIDA N , Yagasaki H, Takahashi Y, Kudo K, et al
     Mutation analysis of SIPA1 in patients with juvenile myelomonocytic leukemia.
     Br J Haematol. 2008;.
     PubMed     Related articles   
     
     
     
121. HOLOWIECKI J , Krawczyk-Kulis M, Giebel S, Jagoda K, et al
     Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study.
     Br J Haematol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
122. LIAPIS K , Bakiri M, Apostolidis J
     Erythroblastic synartesis in a patient with small lymphocytic lymphoma.
     Br J Haematol. 2008;.
     PubMed     Related articles   
     
     
     
123. AL SHAER L , Walsby E, Gilkes A, Tonks A, et al
     Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
     Br J Haematol. 2008;141:483-93.
     PubMed     Related articles    Abstract available
     
     
     
124. KELLY RJ , Wright D, Patil K, Chapple M, et al
     t(14;19)(q32;q13) incidence and significance in B-cell lymphoproliferative disorders.
     Br J Haematol. 2008;141:561-3.
     PubMed     Related articles   
     
     
     
125. MEAD AJ , Gale RE, Kottaridis PD, Matsuda S, et al
     Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.
     Br J Haematol. 2008;141:454-60.
     PubMed     Related articles    Abstract available
     
     
     
126. NAHI H , Selivanova G, Lehmann S, Mollgard L, et al
     Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
     Br J Haematol. 2008;141:445-53.
     PubMed     Related articles    Abstract available
     
     
     
127. CAPELLO D , Deambrogi C, Rossi D, Lischetti T, et al
     Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
     Br J Haematol. 2008;141:504-11.
     PubMed     Related articles    Abstract available
     
     
     
128. KOIKE K , Matsuda K
     Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
     Br J Haematol. 2008;141:567-75.
     PubMed     Related articles    Abstract available
     
     
     
129. BRAUN T , Fenaux P
     Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
     Br J Haematol. 2008;141:576-86.
     PubMed     Related articles    Abstract available
     
     
     
130. ZENZ T , Dohner K, Denzel T, Dohner H, et al
     Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations.
     Br J Haematol. 2008;141:742-3.
     PubMed     Related articles   
     
     
     
131. ROSSI D , De Paoli L, Rossi FM, Cerri M, et al
     Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait.
     Br J Haematol. 2008;141:734-6.
     PubMed     Related articles   
     
     
     
132. SATO T , Toki T, Kanezaki R, Xu G, et al
     Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome.
     Br J Haematol. 2008;141:681-8.
     PubMed     Related articles    Abstract available
     
     
     
133. LEE CY , Tien HF, Hou HA, Chou WC, et al
     Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia.
     Br J Haematol. 2008;141:736-9.
     PubMed     Related articles   
     
     
     
134. FORCONI F , Poretti G, Kwee I, Sozzi E, et al
     High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.
     Br J Haematol. 2008;141:622-30.
     PubMed     Related articles    Abstract available
     
     
     
135. PALMER S , Hanson CA, Zent CS, Porrata LF, et al
     Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.
     Br J Haematol. 2008;141:607-14.
     PubMed     Related articles    Abstract available
     
     
     
136. MOHAMEDBHAI S , Pule M, Conn B, Hopper C, et al
     Acute promyelocytic leukaemia presenting with a myeloid sarcoma of the tongue.
     Br J Haematol. 2008;141:565.
     PubMed     Related articles   
     
     
     
137. DOYEN J , Italiano A, Peyrade F, Bouyer C, et al
     Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia.
     Br J Haematol. 2008;141:744-5.
     PubMed     Related articles   
     
     
     
138. DE LAVALLADE H , Punnialingam S, Milojkovic D, Bua M, et al
     Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis.
     Br J Haematol. 2008;141:745-7.
     PubMed     Related articles   
     
     
     April 2008
139. 
     Abstracts of the British Society of Haematology 48th Annual Scientific Meeting, Incorporating the 6th Bi-Annual I-BFM Leukaemia Symposium. April 7-9, 2008.
     Br J Haematol. 2008;141 Suppl 1:1-121.
     PubMed     Related articles   
     
     
     
140. ANTIC D , Vuckovic M, Elezovic I
     Right atrial myeloid sarcoma causing superior vena cava syndrome.
     Br J Haematol. 2008;141:134.
     PubMed     Related articles   
     
     
     
141. BASECKE J , Podleschny M, Becker A, Seiffert E, et al
     Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
     Br J Haematol. 2008;141:52-9.
     PubMed     Related articles    Abstract available
     
     
     
142. TAM CS , Otero-Palacios J, Abruzzo LV, Jorgensen JL, et al
     Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.
     Br J Haematol. 2008;141:36-40.
     PubMed     Related articles    Abstract available
     
     
     
143. BRITSCHGI C , Jenal M, Rizzi M, Mueller BU, et al
     HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.
     Br J Haematol. 2008;141:179-87.
     PubMed     Related articles    Abstract available
     
     
     
144. BARBARIC D , Corthals SL, Jastaniah WA, Asalanian S, et al
     Detection of WT1-specific T cells in paediatric acute lymphoblastic leukaemia patients in first remission.
     Br J Haematol. 2008;141:271-3.
     PubMed     Related articles   
     
     
     
145. CAMACHO RM , Martin-Noya A
     Pure erythroid leukaemia with leukaemic cells mimicking myeloma cells.
     Br J Haematol. 2008;141:2.
     PubMed     Related articles   
     
     
     March 2008
146. ZENT CS , Ding W, Schwager SM, Reinalda MS, et al
     The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
     Br J Haematol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
147. KELLY K , Murphy K, Farrell M, Rawluk D, et al
     Intracranial small lymphocytic lymphoma.
     Br J Haematol. 2008;.
     PubMed     Related articles   
     
     
     
148. HOFFMANN K , Firth MJ, Beesley AH, Freitas JR, et al
     Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
     Br J Haematol. 2008;140:656-64.
     PubMed     Related articles    Abstract available
     
     
     
149. DE ROMEUF C , Dutertre CA, Le Garff-Tavernier M, Fournier N, et al
     Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16.
     Br J Haematol. 2008;140:635-43.
     PubMed     Related articles    Abstract available
     
     
     
150. NIEMEYER CM , Kratz CP
     Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
     Br J Haematol. 2008;140:610-24.
     PubMed     Related articles    Abstract available
     
     
     
151. KUCHINSKAYA E , Heyman M, Nordgren A, Schoumans J, et al
     Array-CGH reveals hidden gene dose changes in children with acute lymphoblastic leukaemia and a normal or failed karyotype by G-banding.
     Br J Haematol. 2008;140:572-7.
     PubMed     Related articles    Abstract available
     
     
     
152. HAMA A , Yagasaki H, Takahashi Y, Nishio N, et al
     Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
     Br J Haematol. 2008;140:552-61.
     PubMed     Related articles    Abstract available
     
     
     
153. SHANAFELT TD , Geyer SM, Bone ND, Tschumper RC, et al
     CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
     Br J Haematol. 2008;140:537-46.
     PubMed     Related articles    Abstract available
     
     
     
154. FORESTIER E , Heyman M, Andersen MK, Autio K, et al
     Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
     Br J Haematol. 2008;140:665-72.
     PubMed     Related articles    Abstract available
     
     
     
155. HENDERSON MJ , Choi S, Beesley AH, Baker DL, et al
     A xenograft model of infant leukaemia reveals a complex MLL translocation.
     Br J Haematol. 2008;140:716-9.
     PubMed     Related articles   
     
     
     
156. CUTTING R , Taj M, Vora A
     Childhood precursor B-cell acute lymphoblastic leukaemia and monosomy 7 with phenotypic shift at relapse; evidence for the stem cell origins of monosomy 7.
     Br J Haematol. 2008;140:584-6.
     PubMed     Related articles   
     
     
     February 2008
157. SMITH SM , Grinblatt D, Johnson JL, Niedzwiecki D, et al
     Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
     Br J Haematol. 2008;140:313-319.
     PubMed     Related articles    Abstract available
     
     
     
158. PEREZ A , Gonzalez-Vicent M, Ramirez M, Sevilla J, et al
     Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
     Br J Haematol. 2008;140:340-3.
     PubMed     Related articles    Abstract available
     
     
     
159. TIBES R , Kornblau SM, Qiu Y, Mousses SM, et al
     PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation.
     Br J Haematol. 2008;140:344-7.
     PubMed     Related articles    Abstract available
     
     
     
160. HAMBLIN TJ , Davis ZA, Oscier DG
     Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia - long-term follow up of patients with different percentages of mutations.
     Br J Haematol. 2008;140:320-3.
     PubMed     Related articles    Abstract available
     
     
     
161. BLEEKER WK , Munk ME, Mackus WJ, van den Brakel JH, et al
     Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody.
     Br J Haematol. 2008;140:303-12.
     PubMed     Related articles    Abstract available
     
     
     
162. ANTEN S , Heddema ER, Visser O, Zweegman AS, et al
     Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
     Br J Haematol. 2008;140:253.
     PubMed     Related articles   
     
     
     
163. NGO N , Lampert IA, Naresh KN
     Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia.
     Br J Haematol. 2008;140:279-86.
     PubMed     Related articles    Abstract available
     
     
     
164. SUJOBERT P , Bardet V, Bienvenu M
     Images in haematology. Bilateral adrenal chloromas.
     Br J Haematol. 2008;140:254.
     PubMed     Related articles   
     
     
     
165. XU J , Suzuki M, Niwa Y, Hiraga J, et al
     Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome.
     Br J Haematol. 2008;140:394-401.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     January 2008
166. YANO H , Ishida T, Imada K, Sakai T, et al
     Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF.
     Br J Haematol. 2008;.
     PubMed     Related articles       Free Full Text
     
     
     
167. ISKEN F , Steffen B, Merk S, Dugas M, et al
     Identification of acute myeloid leukaemia associated microRNA expression patterns.
     Br J Haematol. 2008;140:153-61.
     PubMed     Related articles    Abstract available
     
     
     
168. OWEN C , Barnett M, Fitzgibbon J
     Familial myelodysplasia and acute myeloid leukaemia--a review.
     Br J Haematol. 2008;140:123-32.
     PubMed     Related articles    Abstract available
     
     
     
169. ROSENBERG PS , Alter BP, Link DC, Stein S, et al
     Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia.
     Br J Haematol. 2008;140:210-3.
     PubMed     Related articles    Abstract available
     
     
     
170. KURODA J , Kimura S, Andreeff M, Ashihara E, et al
     ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
     Br J Haematol. 2008;140:181-90.
     PubMed     Related articles    Abstract available
     
     
     
171. GUINN BA , Bullinger L, Thomas NS, Mills KI, et al
     SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients.
     Br J Haematol. 2008;140:250-1.
     PubMed     Related articles   
     
     
     
172. BULLEY S , Gassas A, Dupuis LL, Aplenc R, et al
     Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation.
     Br J Haematol. 2008;140:214-7.
     PubMed     Related articles    Abstract available
     
     
     
173. RATTHE C , Girard D
     Investigation of the interleukin (IL)-4/IL-4 receptor system in promyelocytic leukaemia PLB-985 cells during differentiation toward neutrophil-like phenotype: mechanism involved in IL-4-induced SOCS3 protein expression.
     Br J Haematol. 2008;140:59-70.
     PubMed     Related articles    Abstract available
     
     
     
174. GABELLONI ML , Borge M, Galletti J, Canones C, et al
     SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression.
     Br J Haematol. 2008;140:117-9.
     PubMed     Related articles   
     
     
     
175. REDDY N , Hernandez-Ilizaliturri FJ, Deeb G, Roth M, et al
     Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.
     Br J Haematol. 2008;140:36-45.
     PubMed     Related articles    Abstract available
     
     
     
176. WHITTLE AM , Howard MR
     Skin lesions in plasmacytoid dendritic cell leukaemia.
     Br J Haematol. 2008;140:121.
     PubMed     Related articles   
     
     
     
177. KIM DH , Lee NY, Lee MH, Sohn SK, et al
     Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients.
     Br J Haematol. 2008;140:71-9.
     PubMed     Related articles    Abstract available
     
     
     
178. GASSAS A , Ishaqi MK, Afzal S, Dupuis A, et al
     Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission: a vital role for graft-versus-host-disease/ graft-versus-leukaemia effect in survival.
     Br J Haematol. 2008;140:86-9.
     PubMed     Related articles    Abstract available
     
     
     December 2007
179. HARDY NM , Grady C, Pentz R, Stetler-Stevenson M, et al
     Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.
     Br J Haematol. 2007;139:824-31.
     PubMed     Related articles    Abstract available
     
     
     
180. GOLDIN LR , Caporaso NE
     Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
     Br J Haematol. 2007;139:774-9.
     PubMed     Related articles    Abstract available
     
     
     
181. SHAPIRO HM
     Cytometry in monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia--the Hunting of the Snark?
     Br J Haematol. 2007;139:772-3.
     PubMed     Related articles    Abstract available
     
     
     
182. SLAGER SL , Kay NE, Fredericksen ZS, Wang AH, et al
     Susceptibility genes and B-chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:762-71.
     PubMed     Related articles    Abstract available
     
     
     
183. RAWSTRON AC , Bennett F, Hillmen P
     The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:724-9.
     PubMed     Related articles    Abstract available
     
     
     
184. LANDGREN O , Kyle RA
     Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases.
     Br J Haematol. 2007;139:717-23.
     PubMed     Related articles    Abstract available
     
     
     
185. NICOLOSO MS , Kipps TJ, Croce CM, Calin GA, et al
     MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:709-16.
     PubMed     Related articles    Abstract available
     
     
     
186. MARTI G , Abbasi F, Raveche E, Rawstron AC, et al
     Overview of monoclonal B-cell lymphocytosis.
     Br J Haematol. 2007;139:701-8.
     PubMed     Related articles    Abstract available
     
     
     
187. VOGT RF , Shim YK, Middleton DC, Buffler PA, et al
     Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies.
     Br J Haematol. 2007;139:690-700.
     PubMed     Related articles    Abstract available
     
     
     
188. VOGT RF , Marti GE
     Overview of monoclonal gammopathies of undetermined significance.
     Br J Haematol. 2007;139:687-9.
     PubMed     Related articles    Abstract available
     
     
     
189. LINET MS , Schubauer-Berigan MK, Weisenburger DD, Richardson DB, et al
     Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.
     Br J Haematol. 2007;139:672-86.
     PubMed     Related articles    Abstract available
     
     
     
190. MCMASTER ML , Caporaso N
     Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
     Br J Haematol. 2007;139:663-71.
     PubMed     Related articles    Abstract available
     
     
     
191. SHIM YK , Silver SR, Caporaso NE, Marti GE, et al
     B cells behaving badly.
     Br J Haematol. 2007;139:658-62.
     PubMed     Related articles    Abstract available
     
     
     
192. CAPORASO N , Goldin L, Plass C, Calin G, et al
     Chronic lymphocytic leukaemia genetics overview.
     Br J Haematol. 2007;139:630-4.
     PubMed     Related articles    Abstract available
     
     
     
193. RAWSTRON AC , Jones RA, Ferguson C, Hughes G, et al
     Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.
     Br J Haematol. 2007;139:845-8.
     PubMed     Related articles    Abstract available
     
     
     
194. RACHEL JM , Zucker ML, Fox CM, Plapp FV, et al
     Monoclonal B-cell lymphocytosis in blood donors.
     Br J Haematol. 2007;139:832-6.
     PubMed     Related articles    Abstract available
     
     
     
195. BLAIR A , Purdue MP, Weisenburger DD, Baris D, et al
     Chemical exposures and risk of chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:753-61.
     PubMed     Related articles    Abstract available
     
     
     
196. PLASS C , Byrd JC, Raval A, Tanner SM, et al
     Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes.
     Br J Haematol. 2007;139:744-52.
     PubMed     Related articles    Abstract available
     
     
     
197. AUER RL , Gribben J, Cotter FE
     Emerging therapy for chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:635-44.
     PubMed     Related articles    Abstract available
     
     
     
198. JOHNSON AJ , Wagner AJ, Cheney CM, Smith LL, et al
     Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:837-44.
     PubMed     Related articles    Abstract available
     
     
     
199. SCAGLIONE BJ , Salerno E, Balan M, Coffman F, et al
     Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
     Br J Haematol. 2007;139:645-57.
     PubMed     Related articles    Abstract available
     
     
     
200. LANDGREN O , Gridley G, Check D, Caporaso NE, et al
     Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:791-8.
     PubMed     Related articles    Abstract available
     
     
     
201. ABBASI F , Longo NS, Lipsky PE, Raveche E, et al
     B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred.
     Br J Haematol. 2007;139:820-3.
     PubMed     Related articles    Abstract available
     
     
     
202. SCHUBAUER-BERIGAN MK , Daniels RD, Fleming DA, Markey AM, et al
     Chronic lymphocytic leukaemia and radiation: findings among workers at five US nuclear facilities and a review of the recent literature.
     Br J Haematol. 2007;139:799-808.
     PubMed     Related articles    Abstract available
     
     
     November 2007
203. TROEGER A , Gudowius S, Escherich G, den Boer ML, et al
     High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
     Br J Haematol. 2007;139:450-7.
     PubMed     Related articles    Abstract available
     
     
     
204. STEENSMA DP , Porcher JC, Hanson CA, Lathrop CL, et al
     Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders.
     Br J Haematol. 2007;139:439-42.
     PubMed     Related articles    Abstract available
     
     
     
205. MADDOCKS-CHRISTIANSON K , Slager SL, Zent CS, Reinalda M, et al
     Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
     Br J Haematol. 2007;139:398-404.
     PubMed     Related articles    Abstract available
     
     
     
206. SHEIKHOLESLAMI MR , Ma W, Uyeji J, Tornyos K, et al
     Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
     Br J Haematol. 2007;139:507-9.
     PubMed     Related articles   
     
     
     
207. BACCHU S , Fegan C, Neal J
     Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
     Br J Haematol. 2007;139:349.
     PubMed     Related articles   
     
     
     
208. GARRATTY G , Petz LD
     Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
     Br J Haematol. 2007;139:622-3.
     PubMed     Related articles   
     
     
     
209. BENNETT F , Rawstron A, Plummer M, de Tute R, et al
     B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle.
     Br J Haematol. 2007;139:600-4.
     PubMed     Related articles    Abstract available
     
     
     
210. NATONI A , MacFarlane M, Inoue S, Walewska R, et al
     TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.
     Br J Haematol. 2007;139:568-77.
     PubMed     Related articles    Abstract available
     
     
     
211. OSHIMI K
     Progress in understanding and managing natural killer-cell malignancies.
     Br J Haematol. 2007;139:532-44.
     PubMed     Related articles    Abstract available
     
     
     October 2007
212. DORES GM , Anderson WF, Curtis RE, Landgren O, et al
     Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
     Br J Haematol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
213. PARNES A , Bifulco C, Vanasse GJ
     A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases.
     Br J Haematol. 2007;139:164-5.
     PubMed     Related articles   
     
     
     
214. ARBER C , Bertrand G, Halter J, Boehlen F, et al
     Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
     Br J Haematol. 2007;139:159-61.
     PubMed     Related articles   
     
     
     
215. WALSBY EJ , Gilkes AF, Tonks A, Darley RL, et al
     FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells.
     Br J Haematol. 2007;139:94-7.
     PubMed     Related articles    Abstract available
     
     
     
216. ESTES DA , Lovato DM, Khawaja HM, Winter SS, et al
     Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
     Br J Haematol. 2007;139:20-30.
     PubMed     Related articles    Abstract available
     
     
     
217. HUGHES C , Patterson K, Murray M
     Avascular necrosis of the femoral head in childhood chronic myeloid leukaemia.
     Br J Haematol. 2007;139:1.
     PubMed     Related articles   
     
     
     
218. BARTAKKE S , Abdelhaleem M, Abla O
     Childhood acute lymphoblastic leukaemia simulating multifocal osteomyelitis.
     Br J Haematol. 2007;139:2.
     PubMed     Related articles   
     
     
     
219. MORRIS ES , Vora A
     Remission induction with single agent Rituximab in a child with multiply relapsed precursor-B ALL.
     Br J Haematol. 2007;139:344-5.
     PubMed     Related articles   
     
     
     
220. NEBRAL K , Konig M, Harder L, Siebert R, et al
     Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
     Br J Haematol. 2007;139:269-74.
     PubMed     Related articles    Abstract available
     
     
     
221. KHARFAN-DABAJA MA , Kumar A, Behera M, Djulbegovic B, et al
     Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?
     Br J Haematol. 2007;139:234-42.
     PubMed     Related articles    Abstract available
     
     
     
222. RICCIONI R , Senese M, Diverio D, Riti V, et al
     M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib-mediated apoptosis.
     Br J Haematol. 2007;139:194-205.
     PubMed     Related articles    Abstract available
     
     
     
223. MCGETTRICK AF , O'Neill LA
     Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.
     Br J Haematol. 2007;139:185-93.
     PubMed     Related articles    Abstract available
     
     
     September 2007
224. MANN G , Attarbaschi A, Burkhardt B, Niggli F, et al
     Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
     Br J Haematol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
225. BOAG JM , Beesley AH, Firth MJ, Freitas JR, et al
     High expression of connective tissue growth factor in pre-B acute lymphoblastic leukaemia.
     Br J Haematol. 2007;138:740-8.
     PubMed     Related articles    Abstract available
     
     
     
226. WILLIMOTT S , Baou M, Naresh K, Wagner SD, et al
     CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
     Br J Haematol. 2007;138:721-32.
     PubMed     Related articles    Abstract available
     
     
     
227. DENNISS FA , Breslin A, Ingram W, Hardwick NR, et al
     The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells.
     Br J Haematol. 2007;138:668-9.
     PubMed     Related articles   
     
     
     
228. OBAMA K , Kubota R, Tara M, Furukawa Y, et al
     Killer cell immunoglobulin-like receptor/3DL2 expression in adult T-cell leukaemia.
     Br J Haematol. 2007;138:666-7.
     PubMed     Related articles   
     
     
     
229. FLOTHO C , Paulun A, Batz C, Niemeyer CM, et al
     AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
     Br J Haematol. 2007;138:644-50.
     PubMed     Related articles    Abstract available
     
     
     
230. SUZUKI R , Onizuka M, Kojima M, Shimada M, et al
     Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
     Br J Haematol. 2007;138:624-31.
     PubMed     Related articles    Abstract available
     
     
     
231. KIM KT , Baird K, Davis S, Piloto O, et al
     Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells.
     Br J Haematol. 2007;138:603-15.
     PubMed     Related articles    Abstract available
     
     
     
232. KNAPPER S
     FLT3 inhibition in acute myeloid leukaemia.
     Br J Haematol. 2007;138:687-99.
     PubMed     Related articles    Abstract available
     
     
     
233. SERRAVALLE S , Purgato S, Melchionda F, Astolfi A, et al
     Trisomy 11 with MLL-PTD in a case of infant AML M0.
     Br J Haematol. 2007;138:817-9.
     PubMed     Related articles   
     
     
     April 2007
234. CONFER DL , Miller JP
     Long-term safety of filgrastim (rhG-CSF) administration.
     Br J Haematol. 2007;137:77-8.
     PubMed     Related articles       Free Full Text
     
     
     
235. LI L , Piloto O, Kim KT, Ye Z, et al
     FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.
     Br J Haematol. 2007;137:64-75.
     PubMed     Related articles    Abstract available
     
     
     
236. BOECKX N , Renard M, Uyttebroeck A
     Acute monocytic leukaemia with histiocytic features.
     Br J Haematol. 2007;137:2.
     PubMed     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: